Hitoshi Toyoda

1.1k total citations
13 papers, 812 citations indexed

About

Hitoshi Toyoda is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hitoshi Toyoda has authored 13 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Hitoshi Toyoda's work include Glycosylation and Glycoproteins Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Hitoshi Toyoda is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Hitoshi Toyoda collaborates with scholars based in Japan and United Kingdom. Hitoshi Toyoda's co-authors include Toshi Komurasaki, Daisuke Uchida, Shigeo Morimoto, Toshiaki Isobe, Kazunori Hanada, Yasuko Takayama, Yuji Shirakata, Yasushi Hanakawa, Sho Tokumaru and Kenshi Yamasaki and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.

In The Last Decade

Hitoshi Toyoda

12 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hitoshi Toyoda Japan	10	432	359	131	99	93	13	812
Laurence Maggiorella France	11	340 0.8×	291 0.8×	81 0.6×	46 0.5×	73 0.8×	17	793
Fumihiko Matsuno Japan	15	590 1.4×	345 1.0×	101 0.8×	62 0.6×	127 1.4×	31	986
Tahereh Kamalati United Kingdom	15	627 1.5×	410 1.1×	61 0.5×	80 0.8×	61 0.7×	41	1.0k
Laura Bald United States	14	487 1.1×	175 0.5×	96 0.7×	46 0.5×	159 1.7×	16	855
Gerard Cowley United Kingdom	16	399 0.9×	426 1.2×	175 1.3×	46 0.5×	200 2.2×	27	1.0k
Ya‐Wei Qiang United States	16	1.1k 2.5×	685 1.9×	63 0.5×	57 0.6×	103 1.1×	35	1.6k
J Bradley Australia	12	405 0.9×	309 0.9×	259 2.0×	37 0.4×	225 2.4×	18	885
Bharati Hukku United States	16	458 1.1×	247 0.7×	45 0.3×	103 1.0×	67 0.7×	29	882
Nancy J. Sipes United States	9	477 1.1×	242 0.7×	53 0.4×	37 0.4×	62 0.7×	11	731
Fiona Zhong United States	9	309 0.7×	258 0.7×	105 0.8×	49 0.5×	376 4.0×	13	908

Countries citing papers authored by Hitoshi Toyoda

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Toyoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Toyoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Toyoda more than expected).

Fields of papers citing papers by Hitoshi Toyoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Toyoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Toyoda. The network helps show where Hitoshi Toyoda may publish in the future.

Co-authorship network of co-authors of Hitoshi Toyoda

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Toyoda. A scholar is included among the top collaborators of Hitoshi Toyoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Toyoda. Hitoshi Toyoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Toyoda, Hitoshi, Akiko Sasaki, Yuta Baba, et al.. (2025). Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice. European Journal of Pharmacology. 999. 177704–177704. 1 indexed citations

Yamamoto, Koji, Shusaku Uchida, Naoki Kojima, et al.. (2011). TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity. British Journal of Pharmacology. 164(1). 181–191. 58 indexed citations

Toyoda, Hitoshi, et al.. (2003). A novel homocysteine‐responsive gene, smap8, modulates mitogenesis in rat vascular smooth muscle cells. European Journal of Biochemistry. 270(11). 2521–2531. 22 indexed citations

Komurasaki, Toshi, Hitoshi Toyoda, Daisuke Uchida, & Nobuo Nemoto. (2002). Mechanism of Growth Promoting Activity of Epiregulin in Primary Cultures of Rat Hepatocytes. Growth Factors. 20(2). 61–69. 31 indexed citations

Toda, Yoshihisa, et al.. (2002). Identification of a novel smooth muscle associated protein, smap2, upregulated during neointima formation in a rat carotid endarterectomy model. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1576(1-2). 225–230. 18 indexed citations

Shirakata, Yuji, Toshi Komurasaki, Hitoshi Toyoda, et al.. (2000). Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes. Journal of Biological Chemistry. 275(8). 5748–5753. 130 indexed citations

Modjtahedi, Helmout, Toshi Komurasaki, Hitoshi Toyoda, & Christopher Dean. (1998). Anti-EGFR monoclonal antibodies which act as EGF, TGFα, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours. International Journal of Cancer. 75(2). 310–316. 25 indexed citations

Shirakata, Yuji, Toshi Komurasaki, Hitoshi Toyoda, et al.. (1998). Epiregulin, a novel member of EGF family, is an autocrine growth factor for normal human keratinocytes. Journal of Dermatological Science. 16. S8–S8.

Komurasaki, Toshi, Hitoshi Toyoda, Daisuke Uchida, & Shigeo Morimoto. (1997). Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tryosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 15(23). 2841–2848. 119 indexed citations

10.

Toyoda, Hitoshi, et al.. (1997). Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochemical Journal. 326(1). 69–75. 109 indexed citations

11.

Isobe, Toshiaki, Hitoshi Toyoda, Toshi Komurasaki, et al.. (1995). Epiregulin. Journal of Biological Chemistry. 270(13). 7495–7500. 234 indexed citations

12.

Toyoda, Hitoshi, Toshi Komurasaki, Yoko Ikeda, Makoto Yoshimoto, & Shigeo Morimoto. (1995). Molecular cloning of mouse epiregulin, a novel epidermal growth factor‐related protein, expressed in the early stage of development. FEBS Letters. 377(3). 403–407. 64 indexed citations

13.

Yamaguchi, Takamasa, et al.. (1986). Angiotensin I converting enzymes in rat epididymis.. Chemical and Pharmaceutical Bulletin. 34(1). 418–422. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact